Malignancy is a risk factor for higher COVID-19 severity:A meta-analysis | Zendy

Gang Liu | Zendy; Wei Cai | Zendy; Huan Liu | Zendy; Hai-Hong Jiang | Zendy; Yong Yi Bi | Zendy; Hong Wang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Malignancy is a risk factor for higher COVID-19 severity:A meta-analysis

Author(s) -

Gang Liu,

Wei Cai,

Huan Liu,

Hai-Hong Jiang,

Yong Yi Bi,

Hong Wang

Publication year - 2021

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-2101-192

Subject(s) - medicine , malignancy , covid-19 , meta analysis , outbreak , disease , risk factor , pathology , infectious disease (medical specialty)

The outbreak of coronavirus disease 2019 (COVID-19) has been an almost global pandemic with significant public health impacts. The increasing prevalence of malignancy has become a leading cause of human mortality. However, conflicting findings have been published on the association between malignancy and COVID-19 severity. This study aims to assess the pooled proportion of malignancy amongst 2019-nCov patients and to investigate the association between malignancy and COVID-19 severity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research